DEFINITIVE PROXY FOR PERIOD ENDING 12/13/02

Company

Eloxx Pharmaceuticals, Inc.

Filed

October 29, 2002

Period of Report

December 13, 2002

Accession Number

0000903100-02-000313

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →